197 related articles for article (PubMed ID: 24685902)
1. Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation.
Wen J; Pei H; Wang X; Xie C; Li S; Huang L; Qiu N; Wang W; Cheng X; Chen L
J Dermatol Sci; 2014 Jun; 74(3):242-50. PubMed ID: 24685902
[TBL] [Abstract][Full Text] [Related]
2. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
[TBL] [Abstract][Full Text] [Related]
3. TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis.
Hvid H; Teige I; Kvist PH; Svensson L; Kemp K
Int Immunol; 2008 Aug; 20(8):1097-106. PubMed ID: 18579711
[TBL] [Abstract][Full Text] [Related]
4. A new selective vascular endothelial growth factor receptor 2 inhibitor ablates disease in a mouse model of psoriasis.
Yan HX; Wang Y; Yang XN; Fu LX; Tang DM
Mol Med Rep; 2013 Aug; 8(2):434-8. PubMed ID: 23732650
[TBL] [Abstract][Full Text] [Related]
5. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
6. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model.
Ren X; Li J; Zhou X; Luo X; Huang N; Wang Y; Chen X; Wei Y
Dermatology; 2009; 219(3):232-8. PubMed ID: 19729876
[TBL] [Abstract][Full Text] [Related]
7. PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines.
Dou R; Liu Z; Yuan X; Xiangfei D; Bai R; Bi Z; Yang P; Yang Y; Dong Y; Su W; Li D; Mao C
PLoS One; 2017; 12(5):e0176823. PubMed ID: 28464025
[TBL] [Abstract][Full Text] [Related]
8. Isoxanthohumol modulates angiogenesis and inflammation via vascular endothelial growth factor receptor, tumor necrosis factor alpha and nuclear factor kappa B pathways.
Negrão R; Duarte D; Costa R; Soares R
Biofactors; 2013; 39(6):608-22. PubMed ID: 23904052
[TBL] [Abstract][Full Text] [Related]
9. Anti-TNF-α monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis.
Liu Y; Yang G; Zhang J; Xing K; Dai L; Cheng L; Liu J; Deng J; Shi G; Li C; Su X; Zhang S; Yang Y; Li J; Yu D; Xiang R; Wei Y; Deng H
Int Immunopharmacol; 2015 Sep; 28(1):731-43. PubMed ID: 26263167
[TBL] [Abstract][Full Text] [Related]
10. Clinical, pathological and immunological features of psoriatic-like lesions affecting keratin 14-vascular endothelial growth factor transgenic mice.
Canavese M; Altruda F; Silengo L; Castiglioni V; Scanziani E; Radaelli E
Histol Histopathol; 2011 Mar; 26(3):285-96. PubMed ID: 21210341
[TBL] [Abstract][Full Text] [Related]
11. The potential of Diosgenin in treating psoriasis: Studies from HaCaT keratinocytes and imiquimod-induced murine model.
Wu S; Zhao M; Sun Y; Xie M; Le K; Xu M; Huang C
Life Sci; 2020 Jan; 241():117115. PubMed ID: 31790685
[TBL] [Abstract][Full Text] [Related]
12. Anti-Angiogenic Efficacy of PSORI-CM02 and the Associated Mechanism in Psoriasis
Lu Y; Yang Y; Zhang J; Zhang H; Ma C; Tang X; Wu J; Li L; Wei J; Chen H; Lu C; Han L
Front Immunol; 2021; 12():649591. PubMed ID: 33995368
[TBL] [Abstract][Full Text] [Related]
13. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
[TBL] [Abstract][Full Text] [Related]
14. Thalidomide Improves Psoriasis-like Lesions and Inhibits Cutaneous VEGF Expression without Alteration of Microvessel Density in Imiquimod- induced Psoriatic Mouse Model.
Liu JH; Wu HH; Zhao YK; Wang F; Gao Q; Luo DQ
Curr Vasc Pharmacol; 2018; 16(5):510-521. PubMed ID: 28982338
[TBL] [Abstract][Full Text] [Related]
15. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
[TBL] [Abstract][Full Text] [Related]
16. Sceptridium ternatum attenuates allergic contact dermatitis-like skin lesions by inhibiting T helper 2-type immune responses and inflammatory responses in a mouse model.
Lim D; Kim MK; Jang YP; Kim J
J Dermatol Sci; 2015 Sep; 79(3):288-97. PubMed ID: 26150208
[TBL] [Abstract][Full Text] [Related]
17. Geniposide alleviates imiquimod-induced psoriasis-like skin lesions in mice via inhibition of angiogenesis.
Chen J; Liu Y; Yin N; Zhao M; Sun X; Zhang Y; Wang Z
Int Immunopharmacol; 2024 May; 132():111923. PubMed ID: 38565041
[TBL] [Abstract][Full Text] [Related]
18. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway.
Jia Z; Nallasamy P; Liu D; Shah H; Li JZ; Chitrakar R; Si H; McCormick J; Zhu H; Zhen W; Li Y
J Nutr Biochem; 2015 Mar; 26(3):293-302. PubMed ID: 25577468
[TBL] [Abstract][Full Text] [Related]
19. Curcumin relieves TPA-induced Th1 inflammation in K14-VEGF transgenic mice.
Sun J; Zhao Y; Jin H; Hu J
Int Immunopharmacol; 2015 Apr; 25(2):235-41. PubMed ID: 25682767
[TBL] [Abstract][Full Text] [Related]
20. Systemic ALA-PDT effectively blocks the development of psoriasis-like lesions and alleviates leucocyte infiltration in the K14-VEGF transgenic mouse.
Chen T; Zhang LW; Fu LX; Wu YB; Liu XY; Guo ZP
Clin Exp Dermatol; 2017 Dec; 42(8):849-856. PubMed ID: 28597992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
